Development of a novel autophagy-related gene model for gastric cancer prognostic prediction

Gastric cancer (GC) is a major global health issue and one of the leading causes of tumor-associated mortality worldwide. Autophagy is thought to play a critical role in the development and progression of GC, and this process is controlled by a set of conserved regulators termed autophagy-related ge...

Full description

Bibliographic Details
Main Authors: Haifeng Xu, Bing Xu, Jiayu Hu, Jun Xia, Le Tong, Ping Zhang, Lei Yang, Lusheng Tang, Sufeng Chen, Jing Du, Ying Wang, Yanchun Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1006278/full
_version_ 1797996372890222592
author Haifeng Xu
Haifeng Xu
Bing Xu
Jiayu Hu
Jun Xia
Le Tong
Ping Zhang
Lei Yang
Lusheng Tang
Sufeng Chen
Jing Du
Ying Wang
Yanchun Li
author_facet Haifeng Xu
Haifeng Xu
Bing Xu
Jiayu Hu
Jun Xia
Le Tong
Ping Zhang
Lei Yang
Lusheng Tang
Sufeng Chen
Jing Du
Ying Wang
Yanchun Li
author_sort Haifeng Xu
collection DOAJ
description Gastric cancer (GC) is a major global health issue and one of the leading causes of tumor-associated mortality worldwide. Autophagy is thought to play a critical role in the development and progression of GC, and this process is controlled by a set of conserved regulators termed autophagy-related genes (ATGs). However, the complex contribution of autophagy to cancers is not completely understood. Accordingly, we aimed to develop a prognostic model based on the specific role of ATGs in GC to improve the prediction of GC outcomes. First, we screened 148 differentially expressed ATGs between GC and normal tissues in The Cancer Genome Atlas (TCGA) cohort. Consensus clustering in these ATGs was performed, and based on that, 343 patients were grouped into two clusters. According to Kaplan–Meier survival analysis, cluster C2 had a worse prognosis than cluster C1. Then, a disease risk model incorporating nine differentially expressed ATGs was constructed based on the least absolute shrinkage and selection operator (LASSO) regression analysis, and the ability of this model to stratify patients into high- and low-risk groups was verified. The predictive value of the model was confirmed using both training and validation cohorts. In addition, the results of functional enrichment analysis suggested that GC risk is correlated with immune status. Moreover, autophagy inhibition increased sensitivity to cisplatin and exacerbated reactive oxygen species accumulation in GC cell lines. Collectively, the results indicated that this novel constructed risk model is an effective and reliable tool for predicting GC outcomes and could help with individual treatment through ATG targeting.
first_indexed 2024-04-11T10:15:18Z
format Article
id doaj.art-b11f460f8d9c445cb3126fe2dd3c63a6
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-11T10:15:18Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-b11f460f8d9c445cb3126fe2dd3c63a62022-12-22T04:29:58ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-10-011210.3389/fonc.2022.10062781006278Development of a novel autophagy-related gene model for gastric cancer prognostic predictionHaifeng Xu0Haifeng Xu1Bing Xu2Jiayu Hu3Jun Xia4Le Tong5Ping Zhang6Lei Yang7Lusheng Tang8Sufeng Chen9Jing Du10Ying Wang11Yanchun Li12Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, ChinaSchool of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, ChinaDepartment of Clinical Laboratory, Hangzhou Women’s Hospital, Hangzhou, ChinaLaboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, ChinaLaboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, ChinaCollege of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United KingdomLaboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, ChinaSchool of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, ChinaLaboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, ChinaLaboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, ChinaLaboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, ChinaDepartment of Central Laboratory, Affiliated Hangzhou first people’s Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Central Laboratory, Affiliated Hangzhou first people’s Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaGastric cancer (GC) is a major global health issue and one of the leading causes of tumor-associated mortality worldwide. Autophagy is thought to play a critical role in the development and progression of GC, and this process is controlled by a set of conserved regulators termed autophagy-related genes (ATGs). However, the complex contribution of autophagy to cancers is not completely understood. Accordingly, we aimed to develop a prognostic model based on the specific role of ATGs in GC to improve the prediction of GC outcomes. First, we screened 148 differentially expressed ATGs between GC and normal tissues in The Cancer Genome Atlas (TCGA) cohort. Consensus clustering in these ATGs was performed, and based on that, 343 patients were grouped into two clusters. According to Kaplan–Meier survival analysis, cluster C2 had a worse prognosis than cluster C1. Then, a disease risk model incorporating nine differentially expressed ATGs was constructed based on the least absolute shrinkage and selection operator (LASSO) regression analysis, and the ability of this model to stratify patients into high- and low-risk groups was verified. The predictive value of the model was confirmed using both training and validation cohorts. In addition, the results of functional enrichment analysis suggested that GC risk is correlated with immune status. Moreover, autophagy inhibition increased sensitivity to cisplatin and exacerbated reactive oxygen species accumulation in GC cell lines. Collectively, the results indicated that this novel constructed risk model is an effective and reliable tool for predicting GC outcomes and could help with individual treatment through ATG targeting.https://www.frontiersin.org/articles/10.3389/fonc.2022.1006278/fullgastric cancerautophagy-related genesprognostic modeltumor immunitydrug resistance
spellingShingle Haifeng Xu
Haifeng Xu
Bing Xu
Jiayu Hu
Jun Xia
Le Tong
Ping Zhang
Lei Yang
Lusheng Tang
Sufeng Chen
Jing Du
Ying Wang
Yanchun Li
Development of a novel autophagy-related gene model for gastric cancer prognostic prediction
Frontiers in Oncology
gastric cancer
autophagy-related genes
prognostic model
tumor immunity
drug resistance
title Development of a novel autophagy-related gene model for gastric cancer prognostic prediction
title_full Development of a novel autophagy-related gene model for gastric cancer prognostic prediction
title_fullStr Development of a novel autophagy-related gene model for gastric cancer prognostic prediction
title_full_unstemmed Development of a novel autophagy-related gene model for gastric cancer prognostic prediction
title_short Development of a novel autophagy-related gene model for gastric cancer prognostic prediction
title_sort development of a novel autophagy related gene model for gastric cancer prognostic prediction
topic gastric cancer
autophagy-related genes
prognostic model
tumor immunity
drug resistance
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1006278/full
work_keys_str_mv AT haifengxu developmentofanovelautophagyrelatedgenemodelforgastriccancerprognosticprediction
AT haifengxu developmentofanovelautophagyrelatedgenemodelforgastriccancerprognosticprediction
AT bingxu developmentofanovelautophagyrelatedgenemodelforgastriccancerprognosticprediction
AT jiayuhu developmentofanovelautophagyrelatedgenemodelforgastriccancerprognosticprediction
AT junxia developmentofanovelautophagyrelatedgenemodelforgastriccancerprognosticprediction
AT letong developmentofanovelautophagyrelatedgenemodelforgastriccancerprognosticprediction
AT pingzhang developmentofanovelautophagyrelatedgenemodelforgastriccancerprognosticprediction
AT leiyang developmentofanovelautophagyrelatedgenemodelforgastriccancerprognosticprediction
AT lushengtang developmentofanovelautophagyrelatedgenemodelforgastriccancerprognosticprediction
AT sufengchen developmentofanovelautophagyrelatedgenemodelforgastriccancerprognosticprediction
AT jingdu developmentofanovelautophagyrelatedgenemodelforgastriccancerprognosticprediction
AT yingwang developmentofanovelautophagyrelatedgenemodelforgastriccancerprognosticprediction
AT yanchunli developmentofanovelautophagyrelatedgenemodelforgastriccancerprognosticprediction